(JWEL) Jamieson Wellness - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA4707481046
JWEL: Vitamins, Minerals, Supplements, Probiotics, Multivitamins, Fish Oils
Jamieson Wellness Inc. (JWEL) is a well-established player in the health and wellness industry, operating with a dual focus that sets it apart. Through its Jamieson Brands segment, the company excels in manufacturing and distributing a comprehensive range of natural health products, including vitamins, minerals, and supplements. This segment is the backbone of their consumer-facing operations, catering to diverse health needs. On the other hand, the Strategic Partners segment leverages their expertise by offering contract manufacturing services, providing tailored solutions to other consumer health companies and retailers. This dual approach not only diversifies their revenue streams but also positions them as both a producer and a partner in the industry.
The companys product portfolio is both extensive and strategic, designed to meet a broad spectrum of consumer demands. Under the Jamieson brand, they offer essential wellness supplements, while Youtheory expands into beauty and wellness products. The Progressive brand delves into foundational formulas, including probiotics, multivitamins, and fish oils, addressing specific health concerns like digestion and sleep. Nurturing a niche market, the Iron Vegan brand provides plant-based options, while Smart Solutions targets womens health issues such as hormone imbalances and stress management. Precision, their sports nutrition line, caters to fitness enthusiasts, ensuring a comprehensive coverage of the health and wellness landscape.
Financially, Jamieson Wellness presents an intriguing profile for investors. With a market capitalization of approximately 1.34 billion CAD, the company has demonstrated stability and growth. The current P/E ratio of 35.16 reflects a premium valuation, possibly indicating market confidence in their growth prospects. The forward P/E of 15.85 suggests that analysts anticipate a moderation in valuation as earnings grow. The price-to-book ratio of 3.03 indicates that investors are willing to pay a premium for the companys assets, which could be attributed to its strong brand portfolio and market position. The price-to-sales ratio of 1.89 highlights reasonable revenue generation relative to its market cap, signaling efficient operations.
Investors should consider the broader context of the health and wellness industry, which is experiencing robust growth driven by increasing consumer focus on preventive health and holistic well-being. Jamieson Wellness, with its nearly century-long history and strong market presence in Canada, coupled with strategic expansions into the U.S. and China, is well-positioned to capitalize on these trends. Their diversified business model, encompassing both branded products and contract manufacturing, provides a balanced approach that can navigate market fluctuations and sustain long-term growth.
Additional Sources for JWEL Stock
JWEL Stock Overview
Market Cap in USD | 947m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
JWEL Stock Ratings
Growth 5y | 19.7% |
Fundamental | 5.61% |
Dividend | 69.5% |
Rel. Strength Industry | -10.5 |
Analysts | - |
Fair Price Momentum | 27.11 CAD |
Fair Price DCF | 11.93 CAD |
JWEL Dividends
Dividend Yield 12m | 2.57% |
Yield on Cost 5y | 3.30% |
Annual Growth 5y | 11.22% |
Payout Consistency | 100.0% |
JWEL Growth Ratios
Growth Correlation 3m | -82.8% |
Growth Correlation 12m | 84.1% |
Growth Correlation 5y | -22.9% |
CAGR 5y | 5.13% |
CAGR/Max DD 5y | 0.11 |
Sharpe Ratio 12m | 0.10 |
Alpha | -11.50 |
Beta | 0.69 |
Volatility | 26.38% |
Current Volume | 40.1k |
Average Volume 20d | 85.3k |
As of February 24, 2025, the stock is trading at CAD 31.14 with a total of 40,115 shares traded.
Over the past week, the price has changed by -2.69%, over one month by -9.32%, over three months by -12.35% and over the past year by +1.75%.
Neither. Based on ValueRay Fundamental Analyses, Jamieson Wellness is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.61 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JWEL as of February 2025 is 27.11. This means that JWEL is currently overvalued and has a potential downside of -12.94%.
Jamieson Wellness has no consensus analysts rating.
According to ValueRays Forecast Model, JWEL Jamieson Wellness will be worth about 31.7 in February 2026. The stock is currently trading at 31.14. This means that the stock has a potential upside of +1.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 41.4 | 32.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 31.7 | 1.9% |